Educational research only—not investment advice or a recommendation. Scores and estimates may use delayed, incomplete, restated, or corrected market and filing data. Independently verify information before making an investment decision.

Ventas, Inc.

VTRNYSE
Wall Street Score · overall investment19/100
$81.07USD$-2.27 (-2.72%)
Company website www.ventasreit.com
Headquarters353 North Clark Street, Chicago, IL, 60654, US
Financial statement currencyUSD · no FX conversion applied
Real Estate · REIT - Healthcare Facilities
Price from Oct 29, 2026Financials updated Oct 27, 2026

VTR · Price history

Price at last available close

$81.07

−$5.84 (-6.72%) 1M

2026-10-28

Tap or drag sideways to inspect a price. Use two fingers to compare automatically. Release to scroll. Use Shift + arrow keys to compare with a keyboard.

Company & revenue

About Ventas, Inc.

Primary reporting period: 2025-12-31 · Research updated Oct 12, 2026. A research update is not a new financial filing.

Who they are

Ventas, Inc. is an S&P 500 company enabling exceptional environments that benefit a large and growing aging population. With approximately 1,450 properties in North America and the United Kingdom, Ventas occupies an essential role in the longevity economy. The Company’s growth is fueled by its more than 900 senior housing communities, which provide valuable services to residents and enable them to thrive in supported environments.

How they make money

Ventas, Inc. is a real estate investment trust (REIT) that generates revenue primarily by owning, managing, and leasing a diversified portfolio of healthcare and senior living properties. The company operates through a senior housing operating portfolio (SHOP) model, triple-net leased properties, and office buildings, while also managing third-party capital through its Ventas Investment Management platform.

Products & services

Ventas provides real estate solutions for the healthcare industry, including senior housing communities, medical office buildings, life science research facilities, and post-acute care centers.

Brands & revenue mix

No separate brand or brand-level revenue disclosure was confirmed in the reviewed sources. This does not mean the company has no brands.

Product / operating segments

Senior Living OperationsUSD 4.28B73.3%

Period ended 2025-12-31Source

Outpatient Medical And Research PortfolioUSD 897.90M15.4%

Period ended 2025-12-31Source

Triple Net Leased PropertiesUSD 601.58M10.3%

Period ended 2025-12-31Source

Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.

Geographic revenue

UNITED STATESUSD 5.21B89.3%

Period ended 2025-12-31Source

CANADAUSD 552.92M9.5%

Period ended 2025-12-31Source

UNITED KINGDOMUSD 71.23M1.2%

Period ended 2025-12-31Source

Calculated from reported segment revenue. Check the source period and revenue basis before comparing shares. Categories can overlap and may not add to 100%.

Customer types

Customer concentration

As of December 31, 2025, the company disclosed significant manager concentration within its SHOP segment, where 39 third-party managers operate 752 properties.

Suppliers, materials & equipment

  • Third-party property managers — The company engages 39 third-party managers to operate properties within its SHOP segment; specific supplier names are not disclosed.Source

Business relationships & partnerships

  • Ventas Investment Management (VIM) — A platform where Ventas partners with third-party institutional investors to invest in real estate through joint ventures and co-investment vehicles.Source

Competitors

  • Welltower Inc. — A major competitor in the healthcare REIT sector, focusing on senior housing and medical office properties.Source
  • Healthpeak Properties, Inc. — A competitor specializing in life science, medical office, and continuing care retirement communities.Source

Strengths

  • Diversified portfolio of high-quality healthcare real estate assetsSource
  • Strong institutional private capital management platformSource

Risks

  • Concentration of senior housing operating portfolio managersSource
  • Sensitivity to changes in healthcare regulations and government reimbursement policiesSource

Wall Street Score

Overall investment score · Quality, value, risk and opportunity

19

Poor

PoorElite

View category scores →

Company Quality

How good is the actual business—regardless of today’s stock price?

33

Poor

Financial Strength

45

Business Quality / Moat

27

Management

13

Growth Quality

49

Risk / Durability

23

Weak Company · Expensive Stock

Uses financial strength, moat, management, growth quality and durability. It excludes share price, P/E, market cap, intrinsic value and margin of safety.

Opportunity

Opportunity Score · How does the current price compare with estimated value?

27

Avoid

Based on current valuation, company quality, recent trends, and available market signals.

View score details →

Model Outlook

12-month model · What does the model think happens next?

34/100

Building Historical Record

Model Score 34/100 — estimates relative performance potential, distinct from the overall Wall Street Score and the separate Company Quality score.

Probability unavailable — the model has not produced a calibrated probability yet.

Click for full breakdown →

WSS View

The quick read

The overall Wall Street Score is low across its combined quality, valuation and risk inputs. This can reflect an expensive share price, business weaknesses, or both; check Company Quality and the category breakdown before drawing a conclusion.

At today’s price, the WSS valuation framework currently reads as less attractive based on the available valuation and market data.

The model outlook is currently cautious.

What we like

No strong positive signal is being highlighted from the currently available summary data.

What to watch
  • •Elevated debt risk
  • •Valuation is a weaker part of the current profile
  • •Revenue fundamentals are weak
  • •Asset quality is a weaker factor

Company-specific research

Questions worth answering for VTR

Research inputs 100% complete

These questions are generated from this company's current financial and score data so the page adds context instead of treating the headline score as a stand-alone conclusion.

  • •Can VTR maintain its current revenue growth rate and improve the amount of that revenue that turns into earnings and cash?
  • •Is VTR's positive free cash flow repeatable, or is the current level being helped by temporary working-capital or spending changes?
  • •Is VTR's debt load manageable relative to cash generation, interest costs and upcoming maturities?
  • •What future growth or profitability would be needed to justify VTR's current valuation?
Elevated debt risk
Business analysis: 17 days ago · Fresh

Essential Investment Snapshot

Wall Street Score

19

0–100 · Poor

Opportunity Score

27

0–100 · Poor

Market Cap

$41.58B

P/E Ratio

151.3

EPS

$0.55

52-Week High

$101.60

52-Week Low

$68.15

Beta

0.74

Intrinsic Value

$18.11

Analyst Target

$99.00

Shares Outstanding

462.6M

Total Revenue

$6.44B

Total Debt

$13.65B

Reported Dividend Yield

2.02%

View dividend history

Liquidation Value / Share

$32.88

Estimated net asset value per share

Momentum & Volatility Signals

Two different market-behavior signals. Momentum measures direction and trend strength. Volatility measures how large and unstable the price moves are, regardless of direction.

0–100 market signals
Momentum
34/ 100
-13 pts / 5d

Weakening momentum

5D -5.0% · 20D -4.6% · RSI 48 · Price vs 20D avg -3.4%
Volatility
31/ 100
+14 pts / 5d

Low movement

20D realized vol 30.7% · 60D 24.3% · Acceleration 1.27x
Momentum = Where is it going?

A high momentum score means price has been trending upward with confirming short- and medium-term strength. A low score means downward or weakening momentum.

Volatility = How violently is it moving?

A high volatility score means larger, less stable price swings. It can happen while a stock is rising or falling, so high volatility is not automatically bullish or bearish.

Important: the volatility score above is based on realized price volatility. Implied volatility (IV) comes from options prices and represents the market's expected future movement. Wall Street Score will keep IV separate and will only display it when a verified options-chain feed is available.

Notices for VTR

Detected from reported data — verify before acting.

Dividend history reported

The provider reports a dividend yield. Confirm the latest declaration before treating it as a current payment.

Elevated debt risk

Total debt is at least one year of revenue • Interest coverage is below 2x • Cash covers less than 20% of total debt

Community Sentiment

0 active · 0 total calls
0% Bullish (0) 0% Bearish (0)

No personal call yet on VTR.

Potential upside factors

  • +Growth opportunities may come from revenue expansion, margin improvement, new products, market-share gains, and stronger cash flow.
  • +Diversified portfolio of high-quality healthcare real estate assets.
  • +Strong institutional private capital management platform.
  • +Positive free cash flow may provide capacity to invest in growth.

Potential downside factors

  • −Debt risk (elevated): Total debt is at least one year of revenue.
  • −Interest coverage is below 2x.
  • −Cash covers less than 20% of total debt.
  • −Concentration of senior housing operating portfolio managers.

These research factors come from saved company research and financial data, not community votes. They are starting points to verify against filings, not buy or sell recommendations.

Create a free account to make a call.

Scores

Click any score for full breakdown
Wall Street Score
Very Weak19/ 100
Weak (0–50)Fair (51–71)Strong (72+)

Poor

19

Tap for breakdown →

Fair

50

Debt Cost4.6%
Debt Reduction YoY3.8%
Debt / Equity1.06x

Tap for breakdown →

Poor

25

Revenue YoY10.4%
Revenue CAGR13.9%
Net Margin4.1%

Tap for breakdown →

Poor

36

Asset Growth YoY5.4%
Liquidation/Share$32.88
Net Assets/MCap0.38x

Tap for breakdown →

Poor

3

Earnings Yield0.6%
Buyback Yield0.0%
Debt Cost4.6%

Tap for breakdown →

Poor

13

ROIC2.9%
ROE1.8%
ROA0.9%

Tap for breakdown →

Poor

27

EPS Growth35.7%
FCF/Share Growth1.3%
Rev/Share Growth4.2%

Tap for breakdown →

Poor

0

Intrinsic Value$18.11
Value Reference$10.86
MOS-359.5%

Tap for breakdown →

Poor

29

Revenue25
Moat27
Valuation0

Tap for breakdown →

Poor

0

MOS %-359.5%
Value Reference$10.86
Deep Discount Reference$7.24

Tap for breakdown →

Poor

15

Interest Coverage1.4x
ROIC2.9%
FCF Yield3.1%

Tap for breakdown →

Poor

12

Financial15
Valuation0
Debt50

Tap for breakdown →

Weak

40

Survival Years-1.2 yrs
Current Ratio0.96x
FCF Margin22.6%

Tap for breakdown →

Was this stock page easy to understand?

One click helps us improve the research experience. This is not tied to an investment decision.

Score Changes

4 historical score records available

Previous Score

19

Oct 26, 2026

Change

+0.1

points

Current Score

19

Oct 27, 2026

Category Changes

Revenue+0.1
Debt0
Assets+0.6
Capital+1.0
Management0
Moat0
Valuation0
Buffett+0.1

VTR increased 0.1 points because overall fundamentals improved.

Projected Score

Projected Score

20

Projected Change

+0.6 points

Preliminary comparable-period financial changes suggest improvement of approximately 0.6 points. This is a projected estimate, not the official WallStreetScore.

Price vs. Value

Overvalued

Current Price

$81.07

Model Intrinsic Value

$18.11

Difference

+$62.96

+347.7% vs IV

Margin of Safety

-347.7%

UndervaluedFair ValueOvervalued
Value Reference: $10.86
Deep Discount Reference: $7.24

Financial Charts

Revenue

201420152016201720182019202020212022202320242025$0$1.5B$3.0B$4.5B$6.0B

Additional Metrics

Operating Cash Flow

201520172019202120232025$0$450M$900M$1.4B$1.8B

Total Debt

201520172019202120232025$0$3.5B$7.0B$10.5B$14.0B

Total Assets

201520172019202120232025$0$7.0B$14.0B$21.0B$28.0B

Net Margin %

No data
Monetary values in USD. Share counts in raw units.

Free includes 3 annual periods plus available TTM; Premium includes up to 10 annual periods. History depends on available company filings. Swipe the table horizontally to see older periods. A dash means unavailable, not zero.

Line ItemTTM2025202420232022202120202019201820172016
Revenue$6.44B$5.83B$4.92B$4.50B····························
Cost of Revenue$6.61B$6.18B$2.83B$2.56B····························
Gross Profit-$166.5M-$344.2M$2.10B$1.94B····························
Research & Development$0.00$0.00$0.00$0.00····························
SG&A Expenses$191.1M$177.4M$163.0M$148.9M····························
Operating Expenses-$999.7M-$1.17B$1.42B$1.52B····························
EBITDA$2.48B$2.24B$1.82B$1.70B····························
Operating Income$833.3M$826.8M$681.2M$415.5M····························
Interest Expense$770.3M$612.2M$602.8M$574.1M····························
Income Before Tax$227.5M$247.4M$50.6M-$39.8M····························
Income Tax Expense-$49.0M-$14.2M-$37.8M-$9.5M····························
Net Income$266.3M$251.4M$81.2M-$41.0M····························
Basic EPS$0.55$0.55$0.20$-0.10····························
Basic Shares483M455M412M402M····························
Diluted Shares492M463M416M406M····························
Upgrade to Premium for up to 10 annual periods, where available.
Upgrade to Premium

Earnings Summary

Estimated earnings date:A future estimated earnings date is not currently available.
Jun 30, 2026Q2FY2026

Revenue

$1.73B

Estimate unavailable.

Revenue Beat/Miss

Not available (no estimate stored)

EPS

$0.14

Estimate unavailable.

EPS Beat/Miss

Not available (no estimate stored)

Debt Change

+2.8%

Cash Change

-67.6%

Margin Change

-0.5 pp

Debt and cash show percentage changes versus the comparison period; margin shows the change in percentage points (pp). These are company-wide changes, not per-share amounts.

Financial Changes Since Prior Period

What Weakened

  • Margins contracted
  • Cash position declined
  • Debt increased

Potential Score Impact

Positive indicators included revenue growth. Pressure indicators included EPS growth, cash levels, debt levels, net income margin. These factors may support or pressure the Revenue, Management, Financial, and Debt categories; this summary does not claim that the stored scores changed.

Stored Earnings Analysis

Revenue increased 21.7%. EPS declined 6.7%. Cash declined 67.6%. Total debt increased 2.8%. Net income margin declined by 0.5 percentage points.

Earnings-Call Transcript

Earnings-call transcript analysis is not currently available.

These results may influence future scores when the next evaluation is completed.

Upgrade to Premium to unlock all earnings history.View plans
Earnings data: 120 days ago · Stale

Insider Activity

Guru / Smart Money

Guru Score

Smart Money

Number of Gurus

Total Guru Value

Avg Portfolio Weight

Largest Holder

Largest Holder %

New Positions

Increased Positions

Reduced Positions

Exited Positions

Net Guru Sentiment

Loading data...

Short Interest

Government disclosed trading activity is available on the Smart Money directory. Filings may be delayed and may not represent complete current holdings.

Dividend History

A dividend is reported, but detailed payment history is temporarily unavailable or awaiting refresh.

Conservative Projected Values

3 Years

$———.——

Premium

5 Years

$———.——

Premium

10 Years

$———.——

Premium

Conservative Projection Rate

——%

Premium

Conservative Projected Values — price projections derived from actual 10-year adjusted historical returns, conservatively adjusted and capped at 8% annually. These are distinct from the Outperformance Model Score and WallStreetScore.

Conservative Projected Values

Premium unlocks the 3-year, 5-year, and 10-year conservative projected values with full calculation breakdowns based on actual historical returns.

Start 7-Day Free Trial

Historical Outperformance Record

Premium includes stored forecasts and any available evaluated results. Completed results, win rates and calibrated probabilities are shown only when supported records exist; access does not create historical outcomes.

Start 7-Day Free Trial

Historical Trends

4 historical records
Jul 24, 26Oct 1, 26Oct 26, 26Oct 27, 260255075100

Historical Score Chart

3 of 4 records shown
3 historical score records are shown. Start your seven-day free trial to unlock 1 more record and the complete score history.Start Free Trial

Wall Street Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Debt Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Revenue Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Asset Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Capital Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Management Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Moat Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Valuation Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Buffett Score

Oct 1, 26Oct 26, 26Oct 27, 260255075100

Intrinsic Value

Oct 1, 26Oct 26, 26Oct 27, 26$16.00$17.00$18.00$19.00$20.00

Value Reference

Oct 1, 26Oct 26, 26Oct 27, 26$8.00$9.00$10.00$11.00$12.00

Margin of Safety %

Oct 1, 26Oct 26, 26Oct 27, 26-3.0%-2.0%-1.0%0.0%1.0%

Related Companies

REIT - Healthcare Facilities

CTRE

CareTrust REIT, Inc.

55Fair
$35.45View

LTC

LTC Properties, Inc.

53Fair
$42.60View

OHI

Omega Healthcare Investors, Inc.

50Fair
$46.13View

NHI

National Health Investors, Inc.

49Weak
$65.68View

XRN

Chiron Real Estate Inc.

45Weak
$28.96View

STRW

Strawberry Fields REIT, Inc.

40Weak
$12.75View

News

Rumor Mill · VTR

Corporate developments & opportunities

Explore market →

No reviewed developments match this filter.

Evidence credibility is not a forecast of stock performance. Rumor Mill is separate from the WSS score.

Related Stock Research

Continue researching this company with related Wall Street Score rankings and investing guides.

Highest Wall Street Score stocksBest growth stocksBest healthcare stocksTop REITsHow Wall Street Score worksHow to analyze a stockUnderstanding financial health

Score Alerts

Premium unlocks alerts when a score rises, falls, or reaches your target price.

Start 7-Day Free Trial

Portfolio Score

Premium unlocks portfolio scoring, strongest and weakest holdings, and overall margin of safety.

Start 7-Day Free Trial